DAVID TERRELL: Open Payments
NPI 1811411754 · LAKE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 36 payments from 14 companies in 2025. Trend: 2023 $192 · 2024 $13 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $182 |
| Lilly USA, LLC | 13 | $149 |
| Phathom Pharmaceuticals, Inc. | 4 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Corcept Therapeutics | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Abbott Laboratories | 1 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: BREZTRI, JARDIANCE, VOQUEZNA, CAPLYTA, Korlym, Sunosi, Kerendia, JOT DX.
Industry payments across FL — which companies pay providers there.
